Author Correction: The promise(s) of mesenchymal stem cell therapy in averting preclinical diabetes: lessons from in vivo and in vitro model systems (Scientific Reports, (2021), 11, 1, (16983), 10.1038/s41598-021-96121-0)

Nagasuryaprasad Kotikalapudi; Samuel Joshua Pragasam Sampath; Sinha Sukesh Narayan; R. Bhonde; Harishankar Nemani; Sathish Kumar Mungamuri; Vijayalakshmi Venkatesan

doi:10.1038/s41598-021-99380-z

Author Correction: The promise(s) of mesenchymal stem cell therapy in averting preclinical diabetes: lessons from in vivo and in vitro model systems (Scientific Reports, (2021), 11, 1, (16983), 10.1038/s41598-021-96121-0)

Nagasuryaprasad Kotikalapudi
, Samuel Joshua Pragasam Sampath
, Sinha Sukesh Narayan
, R. Bhonde
, Harishankar Nemani
, Sathish Kumar Mungamuri
, Vijayalakshmi Venkatesan

Research output: Contribution to journal › Comment/debate

Abstract

The original version of this Article contained an error in the spelling of the author Bhonde R. which was incorrectly given as Bhonde Ramesh R. The original Article and accompanying Supplementary Information file have been corrected.

Original language	English
Article number	19627
Journal	Scientific Reports
Volume	11
Issue number	1
DOIs	https://doi.org/10.1038/s41598-021-99380-z
State	Published - Dec 2021
Externally published	Yes

Access to Document

10.1038/s41598-021-99380-z

Fingerprint

Dive into the research topics of 'Author Correction: The promise(s) of mesenchymal stem cell therapy in averting preclinical diabetes: lessons from in vivo and in vitro model systems (Scientific Reports, (2021), 11, 1, (16983), 10.1038/s41598-021-96121-0)'. Together they form a unique fingerprint.

Cite this

Kotikalapudi, N., Sampath, S. J. P., Sukesh Narayan, S., Bhonde, R., Nemani, H., Mungamuri, S. K., & Venkatesan, V. (2021). Author Correction: The promise(s) of mesenchymal stem cell therapy in averting preclinical diabetes: lessons from in vivo and in vitro model systems (Scientific Reports, (2021), 11, 1, (16983), 10.1038/s41598-021-96121-0). Scientific Reports, 11(1), Article 19627. https://doi.org/10.1038/s41598-021-99380-z

@article{5d5bfc21dcd746a6ae925c25e8e1a635,

title = "Author Correction: The promise(s) of mesenchymal stem cell therapy in averting preclinical diabetes: lessons from in vivo and in vitro model systems (Scientific Reports, (2021), 11, 1, (16983), 10.1038/s41598-021-96121-0)",

abstract = "The original version of this Article contained an error in the spelling of the author Bhonde R. which was incorrectly given as Bhonde Ramesh R. The original Article and accompanying Supplementary Information file have been corrected.",

author = "Nagasuryaprasad Kotikalapudi and Sampath, \{Samuel Joshua Pragasam\} and \{Sukesh Narayan\}, Sinha and R. Bhonde and Harishankar Nemani and Mungamuri, \{Sathish Kumar\} and Vijayalakshmi Venkatesan",

note = "Publisher Copyright: {\textcopyright} The Author(s) 2021",

year = "2021",

month = dec,

doi = "10.1038/s41598-021-99380-z",

language = "English",

volume = "11",

journal = "Scientific Reports",

issn = "2045-2322",

publisher = "Nature Research",

number = "1",

}

Kotikalapudi, N, Sampath, SJP, Sukesh Narayan, S, Bhonde, R, Nemani, H, Mungamuri, SK & Venkatesan, V 2021, 'Author Correction: The promise(s) of mesenchymal stem cell therapy in averting preclinical diabetes: lessons from in vivo and in vitro model systems (Scientific Reports, (2021), 11, 1, (16983), 10.1038/s41598-021-96121-0)', Scientific Reports, vol. 11, no. 1, 19627. https://doi.org/10.1038/s41598-021-99380-z

Author Correction: The promise(s) of mesenchymal stem cell therapy in averting preclinical diabetes: lessons from in vivo and in vitro model systems (Scientific Reports, (2021), 11, 1, (16983), 10.1038/s41598-021-96121-0). / Kotikalapudi, Nagasuryaprasad; Sampath, Samuel Joshua Pragasam; Sukesh Narayan, Sinha et al.
In: Scientific Reports, Vol. 11, No. 1, 19627, 12.2021.

Research output: Contribution to journal › Comment/debate

TY - JOUR

T1 - Author Correction

T2 - The promise(s) of mesenchymal stem cell therapy in averting preclinical diabetes: lessons from in vivo and in vitro model systems (Scientific Reports, (2021), 11, 1, (16983), 10.1038/s41598-021-96121-0)

AU - Kotikalapudi, Nagasuryaprasad

AU - Sampath, Samuel Joshua Pragasam

AU - Sukesh Narayan, Sinha

AU - Bhonde, R.

AU - Nemani, Harishankar

AU - Mungamuri, Sathish Kumar

AU - Venkatesan, Vijayalakshmi

PY - 2021/12

Y1 - 2021/12

N2 - The original version of this Article contained an error in the spelling of the author Bhonde R. which was incorrectly given as Bhonde Ramesh R. The original Article and accompanying Supplementary Information file have been corrected.

AB - The original version of this Article contained an error in the spelling of the author Bhonde R. which was incorrectly given as Bhonde Ramesh R. The original Article and accompanying Supplementary Information file have been corrected.

UR - https://www.scopus.com/pages/publications/85115849307

U2 - 10.1038/s41598-021-99380-z

DO - 10.1038/s41598-021-99380-z

M3 - Comment/debate

C2 - 34584190

AN - SCOPUS:85115849307

SN - 2045-2322

VL - 11

JO - Scientific Reports

JF - Scientific Reports

IS - 1

M1 - 19627

ER -

Kotikalapudi N, Sampath SJP, Sukesh Narayan S, Bhonde R, Nemani H, Mungamuri SK et al. Author Correction: The promise(s) of mesenchymal stem cell therapy in averting preclinical diabetes: lessons from in vivo and in vitro model systems (Scientific Reports, (2021), 11, 1, (16983), 10.1038/s41598-021-96121-0). Scientific Reports. 2021 Dec;11(1):19627. doi: 10.1038/s41598-021-99380-z